Meglumine
"Meglumine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.
Descriptor ID |
D008536
|
MeSH Number(s) |
D02.033.800.813.550 D09.067.342.600 D09.853.813.550
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Meglumine".
Below are MeSH descriptors whose meaning is more specific than "Meglumine".
This graph shows the total number of publications written about "Meglumine" by people in UAMS Profiles by year, and whether "Meglumine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2021 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2019 | 1 | 0 | 1 |
1995 | 0 | 1 | 1 |
1994 | 0 | 1 | 1 |
1992 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Meglumine" by people in Profiles over the past ten years.
-
Kalantari K, Swaminathan S. Use of Gadolinium in Individuals with Reduced Kidney Function. Clin J Am Soc Nephrol. 2021 02 08; 16(2):304-306.
-
Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovasc Imaging. 2021 Feb; 37(2):635-642.
-
Alkhunizi SM, Fakhoury M, Abou-Kheir W, Lawand N. Gadolinium Retention in the Central and Peripheral Nervous System: Implications for Pain, Cognition, and Neurogenesis. Radiology. 2020 11; 297(2):407-416.
-
Lang SM, Alsaied T, Moore RA, Rattan M, Ryan TD, Taylor MD. Conservative gadolinium administration to patients with Duchenne muscular dystrophy: decreasing exposure, cost, and time, without change in medical management. Int J Cardiovasc Imaging. 2019 Dec; 35(12):2213-2219.